These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36849108)

  • 1. Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children.
    Zhang J; Guan J; Tang X; Xu J
    Horm Metab Res; 2023 Apr; 55(4):251-255. PubMed ID: 36849108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
    Coccia F; Testa M; Guarisco G; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):106-113. PubMed ID: 31677889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting C-peptide is a significant indicator of nonalcoholic fatty liver disease in obese children.
    Han X; Xu P; Zhou J; Liu Y; Xu H
    Diabetes Res Clin Pract; 2020 Feb; 160():108027. PubMed ID: 31958476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.
    Peng L; Wu S; Zhou N; Zhu S; Liu Q; Li X
    BMC Pediatr; 2021 Mar; 21(1):122. PubMed ID: 33711964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity.
    Zhang J; Cao J; Xu H; Dong G; Huang K; Wu W; Ye J; Fu J
    J Clin Lab Anal; 2021 Feb; 35(2):e23602. PubMed ID: 33249617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
    Liang S; Cheng X; Hu Y; Song R; Li G
    Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors.
    Thiagarajan S; Shrinuvasan S; Arun Babu T
    Indian J Gastroenterol; 2022 Feb; 41(1):63-68. PubMed ID: 35064452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum prolactin levels were positively related to metabolic indexes and disorders in male obese patients.
    Ke X; Wang L; Zhao Y; Duan L; Deng K; Yao Y; Pan H; Gong F; Zhu H
    Endocrine; 2024 Jun; 84(3):1097-1107. PubMed ID: 38396200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease.
    Pirgon O; Cekmez F; Bilgin H; Eren E; Dundar B
    Obes Res Clin Pract; 2013; 7(4):e275-83. PubMed ID: 24306155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
    Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
    Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease.
    Akcam M; Boyaci A; Pirgon O; Koroglu M; Dundar BN
    Clin Imaging; 2013; 37(3):504-8. PubMed ID: 23601769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses.
    Li Z; Lin M; Liu C; Wang D; Shi X; Chen Z; Liu Y; Yang S; Li X
    Cytokine; 2018 Aug; 108():145-150. PubMed ID: 29609136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease.
    Furthner D; Anderwald CH; Bergsten P; Forslund A; Kullberg J; Ahlström H; Manell H; Ciba I; Mangge H; Maruszczak K; Koren P; Schütz S; Brunner SM; Schneider AM; Weghuber D; Mörwald K
    Front Endocrinol (Lausanne); 2022; 13():830012. PubMed ID: 35185803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of clinical, endocrine and metabolic findings in obese children with and without hepatosteatosis.
    Basarir G; Ozcabi B; Aksu Sayman O; Ozturkmen Akay H; Yildiz FM
    J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1081-1087. PubMed ID: 34142516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.